Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
LA Beste, PK Green, K Berry, MJ Kogut, SK Allison… - Journal of …, 2017 - Elsevier
Background & Aims Hepatitis C virus (HCV) treatment for patients with hepatocellular
carcinoma (HCC) was uncommon before direct-acting antiviral (DAA) medications. Real …
carcinoma (HCC) was uncommon before direct-acting antiviral (DAA) medications. Real …
[HTML][HTML] Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: a systematic literature review and meta-analysis
MJ Zoratti, A Siddiqua, RE Morassut, D Zeraatkar… - …, 2020 - thelancet.com
Background Recent approval and adoption of pangenotypic direct acting antivirals (DAAs)
necessitated a revision of the 2015 World Health Organization guidelines for the …
necessitated a revision of the 2015 World Health Organization guidelines for the …
[HTML][HTML] Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma
Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-
induced hepatocarcinogenesis is a multistep process resulting from a combination of …
induced hepatocarcinogenesis is a multistep process resulting from a combination of …
[HTML][HTML] Antiviral therapy in the palliative setting of HCC (BCLC-B and-C)
M Reig, G Cabibbo - Journal of hepatology, 2021 - Elsevier
The potential impact of direct-acting antivirals (DAAs) in patients with Barcelona Clinic Liver
Cancer (BCLC)-B/C hepatocellular carcinoma (HCC) is understudied. HCC patients have …
Cancer (BCLC)-B/C hepatocellular carcinoma (HCC) is understudied. HCC patients have …
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study
Background Data on HCV‐related hepatocellular carcinoma (HCC) early recurrence in
patients whose HCC was previously cured, and subsequently treated by direct‐acting …
patients whose HCC was previously cured, and subsequently treated by direct‐acting …
Direct-acting antiviral–induced hepatitis C virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis C
J Hengst, CS Falk, V Schlaphoff… - The Journal of …, 2016 - academic.oup.com
Background Persistent infection with hepatitis C virus (HCV) causes profound alterations of
the cytokine and chemokine milieu in peripheral blood. However, it is unknown to what …
the cytokine and chemokine milieu in peripheral blood. However, it is unknown to what …
Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States
Background & Aims Management strategies for patients with hepatitis C virus (HCV)
infection and hepatocellular carcinoma (HCC) have changed, along with liver allocation …
infection and hepatocellular carcinoma (HCC) have changed, along with liver allocation …
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
JM Pascasio, C Vinaixa, MT Ferrer, J Colmenero… - Journal of …, 2017 - Elsevier
Background & Aims Antiviral therapy for the treatment of hepatitis C (HCV) infection has
proved to be safe and efficacious in patients with cirrhosis awaiting liver transplantation (LT) …
proved to be safe and efficacious in patients with cirrhosis awaiting liver transplantation (LT) …
[HTML][HTML] Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030
MW Sonderup, M Afihene, R Ally, B Apica… - The Lancet …, 2017 - thelancet.com
In 2016, WHO adopted a strategy for the elimination of viral hepatitis by 2030. Africa, and
more specifically, sub-Saharan Africa, carries a substantial portion of the global burden of …
more specifically, sub-Saharan Africa, carries a substantial portion of the global burden of …
Unusually high rates of hepatocellular carcinoma after treatment with direct-acting antiviral therapy for hepatitis C related cirrhosis
S Ravi, P Axley, DA Jones, S Kodali, H Simpson… - …, 2017 - gastrojournal.org
Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral
Therapy for Hepatitis C Related Cirrhosis - Gastroenterology Skip to Main Content …
Therapy for Hepatitis C Related Cirrhosis - Gastroenterology Skip to Main Content …